Stryker (SYK) saw a positive improvement to its Relative Strength (RS) Rating on Monday, with an upgrade from 70 to 74.
↑ X NOW PLAYING How To Find Game-Changing StocksThis exclusive rating from Investor's Business Daily identifies market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the last 52 weeks compares to all the other stocks in our database.
Over 100 years of market history shows that the stocks that go on to make the biggest gains often have an 80 or better RS Rating in the early stages of their moves. See if Stryker can continue to rebound and clear that threshold.
How To Invest In Stocks In Both Bull And Bear Markets
Stryker is building a flat base with a 398.20 entry. See if the stock can break out in volume at least 40% higher than normal.
Earnings grew 17% last quarter, up from 11% in the prior report. Revenue also increased, from 9% to 12%. Look for the next report on or around Jan. 28.
The company earns the No. 13 rank among its peers in the Medical-Products industry group. Globus Medical (GMED), Boston Scientific (BSX) and Insulet (PODD) are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。